Share：
Share this content in WeChat
X
[Chinese][PDF]69776
• Editorial •
Status and mission of the breast imaging
ZHOU Chun-wu  ZHANG Ren-zhi 

DOI:10.3969/j.issn.1674-8034.2014.04.001.


[Abstract] Breast cancer is the most common malignant tumor in women. Breast imaging plays an important role in breast cancer diagnosis, choice of treatment, assessment of efficacy and the follow-up monitoring post treatment. In this paper, on the basis of a large number of domestic and foreign literature, the author elaborate the status of the breast imaging methods commonly used (mammography, breast ultrasound, breast MRI, PET-CT and other breast imaging technology) and its clinical application comprehensively and briefly. Combining with their clinical practices, The authors put forward their own views on the development trend of breast imaging and mission in the future.
[Keywords] Breast neoplasms；Diagnostic imaging

ZHOU Chun-wu* Department of Diagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China

ZHANG Ren-zhi Department of Diagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China

*Correspondence to: Zhou CW, E-mail: cjr.zhouchunwu@vip.163.com

Conflicts of interest   None.

Received  2014-04-28
Accepted  2014-05-27
DOI: 10.3969/j.issn.1674-8034.2014.04.001
DOI:10.3969/j.issn.1674-8034.2014.04.001.

[1]
赫捷，陈万青. 2012中国肿瘤登记年报．北京：军事医学科学出版社, 2012: 60-81.
[2]
Pisano ED, Acharyya S, Cole EB, et al. Cancer cases from ACRIN digital mammographic imaging screening trial: radiologist analysis with use of a logistic regression model. Radiology, 2009, 252(2): 348-357.
[3]
Vinnicombe S, Pinto Pereira SM, McCormack VA, et al. Full field digital versus screen film mammography: comparison within the UK breast screening program and systematic review of published data. Radiology, 2009, 251(7): 347-358.
[4]
Sala M, Comas M, Macia F, et al. implementation of digital mammography in a population based breast cancer screening program: effect of screening round on recall rate and cancer detection. Radiology, 2009, 252(1): 31-39.
[5]
Park AM, Franken EA, Garg M, et al. Breast tomosynthesis: present considerations and future applications. Riadiographics, 2007, 27 (Suppl 1), S231-240.
[6]
Poplack SP, Tosteson TD, Kogel CA, et al. Digital breast tomosynthesis: initial experience in 98 women with abnormal digital screening mammography. AJR Am J Roentgenol, 2007, 189(3): 616-623.
[7]
Good WF, Abrams GS, Catullo VJ, et al. Digital breast tomosynthesis: a pilot observer study. AJR Am J Roentgenol, 2008, 190(3): 865-869.
[8]
Bertolini M, Nitrosi A, Borasi G, et al. Contrast detail phantom comparison on a commercially available unit. Digital breast tomosynthesis (DBT) versus full-field digital mammography (FFDM). J Digit Imaging, 2011, 24(1):58-65.
[9]
Hu YH, Zhao W. The effect of angular dose distribution on the detection of microcalcifications in digital breast tomosynthesis. Med physics, 2011, 38(5): 2455-2466.
[10]
Gur D, Abrams GS, Chough DM, et al. Digital breast tomosynthesis: observer performance study. AJR Am J Roentgenol, 2009, 193(3): 586-591.
[11]
Diekmann F, Freyer M, Diekmann S, et al. Evaluation of contrast-enhanced digital mammography. Eur J Radiol, 2011, 78(1):112-121.
[12]
Dromain C, Thibault F, Muller S, et al. Dual-energy contrast-enhanced digital mammography: initial clinical results. Eur J Radiology, 2011, 21(3):565-574.
[13]
Sarah M, Elizabetth A, Richard J, et al. The 2013 Society of Surgical Oncology Susan G. Komen for the Symposium. MRI in Breast Cancer: Where Are We Now? Ann Surg Oncol, 2014, 21(1): 28-36.
[14]
刘佩芳，鲍润贤，王琦．规范乳腺MRI检查适应证、检查技术和诊断中国医学计算机成像杂志, 2008, 14(6): 507-515.
[15]
赵莉云,周纯武,李静. 2012年北美放射学年会乳腺影像学研究进展.磁共振成像, 2013, 4(2): 156-159.
[16]
汪晓红,彭卫军,谭红娜,等.氢质子磁共振波谱监测乳腺癌新辅助化疗疗效的应用研究.磁共振成像, 2010, 16(1): 20-24.
[17]
Lo GG, Ai V, Chan JK, et al. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T. J Comput Assist Tomogr, 2009, 33(1): 63-69.
[18]
Nilsen L, Fangberget A, Geier O, et al. Diffusion-weighted magnetic resonance imaging for pretreatment predicion and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Acta Oncol, 2010, 49(3): 354-360.
[19]
Chen X, Li WL, Zhang YL, et al. Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions. BMC Cancer, 2010, 10: 693.
[20]
Baltzer PA, Schafer A, Dietzel M, et al. Diffusion tensor magnetic resonance imaging of the breast: a pilot study. Eur J Radiol, 2011, 21(1):1-10.
[21]
Ah-See ML, Makris A, Taylor NJ, et al. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer. Clin Cancer Res, 2008, 14(20): 6580-6589.
[22]
Stefan P, Ricardo O, Stephen R, et al. MR spectoscopicimaging: pringciples and recent advances. J Magn Reson Imaging, 2013, 37(3): 1301-1325.
[23]
Danishad KK, Sharma U, Sah RG, et al. Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI). NMR Biomed, 2010, 23(3): 233-241.
[24]
Dorrius MD, Pijnappel RM, Jansen-van der Weide MC, et al. Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions. Radiology, 2011, 259(3): 695-703.
[25]
Bathen TF, Heldahl MG, Sitter B, et al. In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response. MAGMA, 2011, 24(6): 347-357.
[26]
Carbognin G, Girardi V, Brandalise A, et al. MR-guided vacuum-assisted breast biopsy in the management of incidental enhancing lesions detected by breast MR imaging. Radiol Med, 2011, 116(6): 876-885.
[27]
Ramon CG, Framcisco SP, Mercedes AB, et al. The current role of radiologists in a multidisciplinary team treating breast cancer. Diagn Interv Radiol, 2013, 19(4): 377-386.
[28]
Atkins J, Al Mushawah F, Appleton CM, et al. Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors. J Surg Res, 2012, 177(1): 109-115.

PREV The clinical progress of MRI in the implantation (intrusive) of placenta praevia
NEXT Differentiation of phyllodes breast tumors from fibroadenomas using MRI
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn